Matt Addie
AstraZeneca (United Kingdom)(GB)
Research Areas
PI3K/AKT/mTOR signaling in cancer, Melanoma and MAPK Pathways, Protein Tyrosine Phosphatases, Quinazolinone synthesis and applications, Biochemical and Molecular Research
Most-Cited Works
- → Discovery of 4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an Orally Bioavailable, Potent Inhibitor of Akt Kinases(2013)213 cited
- Discovery of 4-amino-<em>N</em>-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7<em>H</em>- pyrrolo[2,3-<em>d</em>]pyrimidin-4-yl)piperidine-4-carboxamide (AZD5363), an orally bioavailable, potent inhibitor of Akt kinases(2013)